• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

Human Papilloma Virus, Squamous Cell Carcinoma Antigen and Epidermal Growth Factor Receptor as Biological Markers in Sinonasal Inverted Papilloma

    Ibrahim El- Dsoky Abdelaleem Al- Gendy Mohamed Shams Eldin

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 107-116

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Sinonasal inverted papilloma (SIP) has a recurrent tendency and potential for transformation into squamous cell carcinoma and is a locally aggressive benign tumor. In the progression from benign SIP to malignancy, human papillomavirus (HPV) and epidermal growth factor receptor (EGFR) are suggested to play a major role. This work aims to assess their role as tumor marker in SIP. Immunohistochemical analysis for EGFR and PCR detection of HPV – DNA were estimated in nasal biopsies from 35 SIP, 35 NP and 30 control patientsv (turbinate surgery candidate). Serum SCCA1 was also assessed. HPV-DNA was detected as 63%, 8.6% and 0 % in SIP, NP, and control patients. EGFR intensity revealed statistically significant difference between SIP and other groups. Significant elevated serum SCCA level (6.14 ± 2.69 ng/ml) was found in SIP group, compared to 2.41 ± 1.12 ng/ml and 0.68 ± 0.25 ng/ml in NP and control group. There was a significant decrease of its level postoperatively. The sensitivity was 80.0 and the specificity was 93.8. These results may suggest SCCA and EGFR are possible reliable tumor markers in SIP monitoring and management. High prevalence of HPV-DNA points to its possible role as etiological factor for SIP.
Keywords:
    Sinonasal inverted papilloma squamous cell carcinoma antigen Human Papilloma Virus epidermal growth factor receptor biological markers
  • PDF (300 K)
  • XML
(2021). Human Papilloma Virus, Squamous Cell Carcinoma Antigen and Epidermal Growth Factor Receptor as Biological Markers in Sinonasal Inverted Papilloma. European Journal of Molecular & Clinical Medicine, 8(3), 107-116.
Ibrahim El- Dsoky; Abdelaleem Al- Gendy; Mohamed Shams Eldin. "Human Papilloma Virus, Squamous Cell Carcinoma Antigen and Epidermal Growth Factor Receptor as Biological Markers in Sinonasal Inverted Papilloma". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 107-116.
(2021). 'Human Papilloma Virus, Squamous Cell Carcinoma Antigen and Epidermal Growth Factor Receptor as Biological Markers in Sinonasal Inverted Papilloma', European Journal of Molecular & Clinical Medicine, 8(3), pp. 107-116.
Human Papilloma Virus, Squamous Cell Carcinoma Antigen and Epidermal Growth Factor Receptor as Biological Markers in Sinonasal Inverted Papilloma. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 107-116.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 311
  • PDF Download: 375
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus